Tag Archives: WHO

Innovation

(SpicyIP Tidbit) India signs Landmark Collaboration Agreement with WHO to promote Traditional Medicine Systems

by
Leave a Comment

In a press release dated 14th May 2016, the Ministry of AYUSH has declared that it has inked a major collaboration agreement with the World Health Organization “for cooperation on promoting the quality, safety and effectiveness of service provision in traditional and complementary medicine (T&CM)”. This historic Project Collaboration Agreement (PCA) will operate between 2016 and 2020. It will be seminal in the creation of the first ever WHO benchmark document for training in Yoga and similar WHO benchmark documents…


Read More »
Biological Diversity Copyright Drug Regulation Patent Trademark Traditional Knowledge

Need Your Feedback: Report on Indian IP and Public Health

by
2 Comments

A month or so ago, I’d sent around an email to our SpicyIP mailing group asking for inputs on a report on IP and public health (for the WHO India Office). The report (authored by some of the SpicyIP team) deals with patents for the most part, but also contains chapters on trademarks, copyrights and traditional knowledge/biodiversity. The idea was that it would serve as a basic primer for those interested in a quick overview of the key legal issues around…


Read More »
Drug Regulation Trademark

The "Spuriousness" of Indian Law: Delinking IP from Drug Regulation

by
2 Comments

The Indian Express published an editorial of mine, where I argue that India needs to urgently amend the definition of “spurious” drugs and delink drug regulation from IP. Saying No to the Wrong Drugs The Drugs and Cosmetics Act (DCA) was recently amended to mandate significantly enhanced penalties for those trafficking in “spurious” drugs. While this attempt to counter the menace of harmful drugs is laudable, the term “spurious” itself is loosely worded and could be interpreted to include even…


Read More »
Others

The Purse May not Open for All: NGO’s Advocate Greater Transparency in the Functioning of WHO Expert Working Group on R&D Financing

by
Leave a Comment

In November, 2008, the WHO had established an Expert Working Group on R&D Financing (EWG) for examining the existing financing and coordination of R&D and for reviewing proposals for new and innovative sources of funding to stimulate R&D related to diseases designated Type II and Type III and to identify the specific R&D needs of developing countries in relation to Type I diseases. Consisting of 24 experts and policy makers, the EWG is supposed to submit a final report to…


Read More »